A new study led by Australian veterinarians has exposed the challenge of identifying pain in horses with gastric ulcers and highlights an urgent need to better detect when horses are suffering.

Sunil Sharma, M.D., FACP, M.B.A., director of the Center for Translational Science at HonorHealth Research Institute, has been named by the Arizona Bioindustry Association (AZBio) as the Arizona Bioscience Researcher of the Year.

Many Australian veterans seek alcohol and other drug (AOD) care in mainstream services, where veteran status is not routinely identified – but Flinders University researchers present a solution to ensure that veterans with care needs are more visible and clearly recognised.

A five-year, $3.46 million grant from the National Cancer Institute recently was awarded to The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute and the University of California San Francisco. The grant will help researchers study why some patients with acute myeloid leukemia respond to treatment while others don't. The findings could help doctors predict which patients will benefit from certain therapy before treatment even begins.

A higher ultra processed food (UPF) intake is linked to a heightened risk of several major chronic health issues, such as digestive diseases, high blood pressure, and metabolic syndrome/diabetes, as well as death, finds a pooled data analysis of the available evidence, published in the open access journal Family Medicine and Community Health.

A 30-day course of benznidazole taken once a day could offer people with chronic Trypanosoma cruzi infection a safer and more practical option than the current standard treatment, taken twice a day for 60 days. The TESEO trial, co-led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the “la Caixa” Foundation, the University of Texas at El Paso (UTEP, USA), and CEADES (Bolivia), reports these results in The Lancet Infectious Diseases.

A large prospective study published today in Nature Medicine found that a blood test designed to detect multiple cancers identified cancer signals across 17 broad cancer types, such as ovarian, lung, breast and colorectal cancers, and many which do not have recommended screening tests.